⚡ Quick Answer — What is Seretide Accuhaler?
Seretide Accuhaler is a dry-powder combination inhaler (DPI) from GSK containing fluticasone propionate (an inhaled corticosteroid, ICS) plus salmeterol xinafoate (a long-acting beta-2 agonist, LABA). Three strengths are available: 50/100 mcg, 50/250 mcg, and 50/500 mcg (salmeterol / fluticasone per blister). Used as a preventer/controller inhaler in moderate-to-severe persistent asthma and in COPD with an exacerbation history. One inhalation twice daily, roughly 12 hours apart. Rinse mouth with water after every dose to prevent oral thrush and hoarse voice — this single habit prevents the two most common side effects. Not a reliever — you still need a short-acting bronchodilator (SABA like salbutamol/albuterol) for sudden attacks. Never use salmeterol-only inhalers for asthma (FDA boxed warning); the combination ICS-LABA product resolves that risk.
📦 Every order is covered by our Reshipment Assurance Policy — if your parcel does not arrive within 20 business days, we reship it.
Why order from MedsBase
Our generic medications are sourced from WHO-GMP certified manufacturers and shipped worldwide in discreet, plain packaging — no medication name on the parcel exterior. Card payments are routed through a regulated processor (statement descriptors include a regulated card-payment processor — never “MedsBase” or any medication name). Crypto and SEPA bank transfer are also accepted. Every order is backed by our Reshipment Assurance Policy.
What Is Seretide Accuhaler?
Seretide Accuhaler is a combination dry-powder inhaler (DPI) from GlaxoSmithKline (GSK) containing two active ingredients — fluticasone propionate, an inhaled corticosteroid (ICS), and salmeterol xinafoate, a long-acting beta-2 agonist (LABA). It is the brand sold in Europe, Asia, Australia and most of the world; the same salmeterol/fluticasone combination is marketed as Advair Diskus in the United States and Canada, and as Seroflo and Salmeflo in several generics markets.
The Accuhaler (known as the Diskus in North America) is a disc-shaped DPI holding 60 pre-metered blister doses. A lever mechanism pierces one blister per actuation — no spacer, no propellant, no priming required. Three strengths are available worldwide, all delivering 50 mcg of salmeterol per dose, paired with 100, 250 or 500 mcg of fluticasone: 50/100, 50/250, and 50/500 mcg. The strength is chosen by the prescriber based on asthma severity and previous ICS dose.
Seretide Accuhaler is a preventer (controller) inhaler, not a reliever. It is taken regularly twice daily to keep asthma or COPD under long-term control and does not replace the need for a rescue reliever such as salbutamol (Asthalin, Ventolin) for sudden symptoms. For adults and adolescents with asthma, current GINA guidance favours ICS-formoterol (Foracort / Symbicort) for the combined preventer + reliever role in many regimens, but ICS-salmeterol (Seretide Accuhaler) remains a first-line controller for Step 3–5 asthma and for COPD with frequent exacerbations.
How Does Seretide Accuhaler Work?
The two actives target different mechanisms of airway disease and are synergistic when given together:
- Fluticasone propionate (ICS) — a potent topical corticosteroid that reduces airway inflammation by suppressing the recruitment and activation of eosinophils, mast cells, T-lymphocytes and macrophages in the bronchial mucosa. Over 2–4 weeks of regular use this reduces mucus production, airway wall swelling and the bronchial hyper-responsiveness that drives asthma attacks.
- Salmeterol xinafoate (LABA) — a highly selective long-acting beta-2 agonist that relaxes bronchial smooth muscle for approximately 12 hours per dose. Onset is slower than salbutamol (peak effect around 2–3 hours) but the duration means twice-daily dosing covers all 24 hours of bronchodilation.
Combining them lets the steroid treat the underlying inflammation while the LABA keeps the airway open, so most patients need a lower total steroid dose than they would on an ICS alone, and they get better lung function between doses.
Uses and Indications
- Moderate-to-severe persistent asthma in patients aged 4 years and above whose symptoms are not adequately controlled on an ICS alone, or whose asthma severity warrants combination therapy from the outset.
- Chronic obstructive pulmonary disease (COPD) with an FEV1 below 60% predicted and a history of exacerbations, to reduce exacerbation frequency and improve lung function. The 50/500 mcg strength is the usual COPD dose.
- Step-up therapy from an ICS-only inhaler (e.g. fluticasone alone) when symptoms persist despite good inhaler technique.
- Maintenance after a severe asthma exacerbation — when stepping down from oral corticosteroid courses.
Seretide Accuhaler is not for: sudden asthma attacks (use a SABA reliever), primary treatment of status asthmaticus, or as monotherapy when a SABA alone would suffice (mild intermittent asthma — Step 1).
Seretide Accuhaler Dosage
| Indication | Strength | Dose |
|---|---|---|
| Adult asthma — moderate | 50/100 mcg | 1 inhalation twice daily |
| Adult asthma — moderate-severe | 50/250 mcg | 1 inhalation twice daily |
| Adult asthma — severe | 50/500 mcg | 1 inhalation twice daily |
| COPD | 50/500 mcg | 1 inhalation twice daily |
| Children 4–11 years | 50/100 mcg only | 1 inhalation twice daily (specialist initiation) |
How to Use the Accuhaler Properly
- Hold the device horizontally. Slide the thumb grip until it clicks — this opens the mouthpiece cover.
- Slide the lever away from you until it clicks. You will hear a second click as a blister is pierced and the dose is loaded. The dose counter decreases by one.
- Breathe out gently away from the mouthpiece. Do not exhale into the device — humid breath ruins the powder.
- Place the mouthpiece between your lips, seal tightly, and inhale forcefully and deeply through the mouth (a strong, fast breath — the Accuhaler requires a higher inspiratory effort than an HFA inhaler).
- Hold your breath for 5–10 seconds, then exhale slowly through the nose.
- Close the device by sliding the cover back over the mouthpiece.
- Rinse your mouth with water and spit — do not swallow. This one habit prevents oral candidiasis (thrush) and hoarseness.
- Use at the same two times each day (e.g. 8 am and 8 pm). Take missed doses if you remember within 6 hours; otherwise skip and take the next dose on schedule — do not double up.
The Accuhaler has a numeric dose counter on the top of the device. Numbers 5–0 turn red to warn you that fewer than five doses remain and a new device is needed.
Side Effects of Seretide Accuhaler
Common (prevented mostly by rinsing after each dose):
- Oral candidiasis (thrush) — white patches on the tongue or inner cheek
- Hoarseness / dysphonia
- Throat irritation, dry mouth
- Headache
- Mild tremor (salmeterol effect)
- Palpitations (transient)
Less common:
- Upper respiratory tract infections, sinusitis
- Muscle cramps (LABA effect)
- Adrenal suppression with high doses (50/500 long-term)
- Reduced bone mineral density with high-dose long-term use
- Pneumonia — small but real increased risk in COPD patients on ICS (FDA label caution)
Serious (stop and seek medical review):
- Paradoxical bronchospasm — worsening wheeze or tightness immediately after a dose. Stop the inhaler and use a SABA reliever; contact your prescriber.
- Severe allergic reactions (urticaria, angio-oedema, anaphylaxis)
- Cushingoid features, adrenal crisis symptoms (fatigue, weakness, hypotension) with prolonged high-dose use
- Growth suppression in children on long-term high-dose ICS — monitor height yearly on 50/100
Warnings and Precautions
- FDA black-box warning — LABA monotherapy in asthma: salmeterol alone increases asthma-related death. The combination product resolves this risk; never substitute a LABA-only inhaler for Seretide Accuhaler.
- Always carry a SABA reliever (salbutamol / albuterol / Asthalin). Seretide Accuhaler is not for acute attacks.
- Step-down with caution. Do not stop abruptly — step down under medical supervision to avoid rebound.
- Rinse your mouth after every dose. This is the single most effective prevention of thrush and hoarseness.
- Cardiovascular: use cautiously in severe coronary disease, arrhythmias, uncontrolled hypertension, hyperthyroidism or phaeochromocytoma.
- Diabetes: high-dose salmeterol can transiently elevate glucose.
- Children under 4 years should not use the Accuhaler.
- Pregnancy and breastfeeding: continue well-controlled asthma treatment in pregnancy — uncontrolled asthma is more dangerous than the medication. Discuss dose with prescriber.
- Annual adrenal-axis review on the 50/500 strength long-term.
Contraindications
- Known hypersensitivity to fluticasone propionate, salmeterol or lactose (the carrier) — the powder contains lactose monohydrate which may contain trace milk proteins
- Severe cow's milk protein allergy (refer to prescriber)
- Status asthmaticus / acute severe asthma — use nebulised bronchodilators and systemic steroids instead
- Children under 4 years
Drug Interactions
| Interacting drug | Effect | What to do |
|---|---|---|
| Strong CYP3A4 inhibitors (ritonavir, ketoconazole, itraconazole, clarithromycin) | Increase systemic fluticasone — risk of Cushingoid features and adrenal suppression | Avoid combination if possible; monitor for steroid side-effects if unavoidable |
| Beta-blockers (non-selective: propranolol, timolol eye drops) | Block salmeterol's bronchodilation — can precipitate severe bronchospasm | Avoid non-selective beta-blockers; use cardioselective (bisoprolol, metoprolol) if beta-blocker essential |
| Diuretics (loop, thiazide) | Additive hypokalaemia with high-dose LABA | Monitor serum potassium if co-prescribed long-term |
| Other LABAs (formoterol, olodaterol) or LAMA-LABA combos | Duplicate therapy — increased systemic beta-2 effect | Do not stack combination inhalers without specialist review |
| MAOIs, tricyclic antidepressants | Potentiate cardiovascular effects of salmeterol | Use with caution; monitor BP and heart rate |
| Short-acting beta-2 agonists (salbutamol, terbutaline) for rescue | Additive effect — but essential for acute relief | Continue rescue SABA as prescribed |
Storage
- Store below 30°C in a dry place. Do not refrigerate or freeze.
- Keep the device in its foil-wrapped pouch until first use.
- Discard 2 months after opening the pouch or when the dose counter reaches 0 — whichever comes first.
- Do not get the device wet. Replace the mouthpiece cover after every use.
Related Alternatives on MedsBase
- Asthalin Inhaler (salbutamol HFA 100 mcg) — reliever MDI
- Asthalin Respules (salbutamol 2.5 mg nebuliser solution) — acute relief
- Duolin Inhaler (salbutamol + ipratropium HFA) — COPD combination reliever
- Budecort Respules (budesonide nebuliser suspension) — nebulised preventer
- Foracort Inhaler (formoterol + budesonide DPI/HFA) — ICS-LABA combo
Frequently Asked Questions
Is Seretide Accuhaler the same as Advair Diskus?
Yes — the same salmeterol 50 mcg + fluticasone propionate formulation is sold as Advair Diskus in the USA and Canada, as Seretide Accuhaler in Europe/UK/Asia/Australia, and as Seroflo and Salmeflo in several generic markets. The device, strengths and clinical indications are identical.
Can Seretide Accuhaler be used as a reliever for sudden asthma attacks?
No. Salmeterol is long-acting but slow-onset (peak 2–3 hours). For acute symptoms, use a short-acting beta-2 agonist reliever such as salbutamol / albuterol (Asthalin, Ventolin). Always carry a reliever even when you are well.
How do I avoid oral thrush from Seretide Accuhaler?
Rinse your mouth with water and spit after every dose. You can also gargle briefly. This clears residual fluticasone powder from the oropharynx and is the single most effective prevention for thrush and hoarseness. If thrush does develop (white patches on the tongue or inner cheek), ask your prescriber for nystatin oral suspension or fluconazole.
Is the Accuhaler the same as the Evohaler / HFA inhaler?
No — the Evohaler (Seretide HFA in the EU, also sold as the MDI version) is a pressurised metered-dose inhaler that requires a coordinated slow breath and a spacer for best delivery. The Accuhaler (Diskus) is a dry-powder inhaler that requires a strong, fast inhalation and no coordination with actuation. Choose by inspiratory flow ability: children and severe COPD often prefer HFA + spacer; adults with adequate inspiratory flow often prefer the Accuhaler.
Which strength should I use?
Your prescriber chooses the strength. As a rough guide: 50/100 mcg is for step-up asthma from an ICS alone; 50/250 mcg is a common moderate-severe asthma dose; 50/500 mcg is for severe asthma or for COPD with exacerbations. Never change the strength yourself — step-ups and step-downs need a review.
Can I use Seretide Accuhaler during pregnancy?
Yes — uncontrolled asthma in pregnancy is more dangerous (for both mother and baby) than the tiny systemic absorption of inhaled fluticasone and salmeterol. Guidelines (GINA, UK BTS/SIGN) recommend continuing the same controller regimen that was working before pregnancy. Discuss any planned changes with your prescriber.
Will Seretide Accuhaler stunt my child's growth?
Long-term high-dose ICS can transiently reduce growth velocity in children — typically 0.5–1 cm in the first year of treatment — but children generally catch up to their genetic target height by adulthood. For children on the 50/100 strength, measure height yearly and step down to the lowest effective dose whenever asthma is stable. Uncontrolled asthma itself suppresses growth more than ICS use.
What is the black-box warning about LABAs and asthma?
Salmeterol used alone as monotherapy in asthma increases the risk of severe exacerbations and asthma-related death (the SMART trial, 2006). The combination product (Seretide Accuhaler) includes an ICS, which eliminates that excess risk — confirmed by four large FDA-mandated safety trials published 2016–2018. The warning remains on LABA-only inhalers (salmeterol Serevent, formoterol Foradil) but does not apply to Seretide Accuhaler or other ICS-LABA combinations used as directed.
How do I know when my Seretide Accuhaler is empty?
The top of the Accuhaler has a dose counter that starts at 60 and decreases by one with each actuation. When the counter shows numbers 5 to 0 in red, you have fewer than five doses remaining and should get a replacement. At 0 the device will no longer deliver drug.
Can I share my Seretide Accuhaler with someone else?
No. Inhalers are personal devices — sharing spreads respiratory infections and the dose is titrated to one patient's disease severity. The person you are trying to help may need a very different strength, or a different class of inhaler entirely.
How to use the Seretide Accuhaler correctly — step-by-step
The Accuhaler is a multi-dose dry powder inhaler. Using it incorrectly is the single most common reason Seretide does not work as well as expected. Studies of community asthma populations show 40–60% of patients use Accuhaler-style devices with at least one critical error. Get the technique right and the same dose works dramatically better.
- Open the device. Hold the Accuhaler in one hand and put the thumb of your other hand on the thumbgrip. Push the thumbgrip away from you as far as it will go until you hear a click.
- Slide the lever. Hold the Accuhaler with the mouthpiece toward you. Slide the lever away from you as far as it will go until it clicks. The Accuhaler is now ready — you have one dose loaded.
- Breathe out fully, AWAY FROM the mouthpiece. Never breathe out into the device — moisture from your breath ruins the dry powder.
- Place the mouthpiece between your lips and form a tight seal. Tilt the Accuhaler slightly downward so the mouthpiece is below the level of the teeth.
- Breathe in steadily, deeply and forcefully through the mouth. This is the opposite of an MDI — DPIs need a fast inspiratory flow (≥ 30 L/min, ideally 60+) to deaggregate the powder and carry it into the lungs.
- Hold your breath for 10 seconds (or as long as comfortable), then breathe out slowly away from the device.
- Close the Accuhaler by sliding the thumbgrip back toward you until it clicks shut. The lever resets automatically.
- Rinse your mouth with water and spit out after every dose. The fluticasone steroid component causes oral thrush and dysphonia (hoarse voice) if not rinsed out — this is the second most common avoidable problem after wrong technique.
Common mistakes that cut your dose in half
- Breathing in too slowly. The Accuhaler needs forceful inhalation. Without it, the active drug stays in the device. If you struggle to inhale forcefully (severe COPD, frail elderly), discuss whether a metered-dose inhaler with spacer would work better.
- Breathing out into the mouthpiece. Your breath has water vapour; the dry-powder formulation clumps. Always exhale away from the device.
- Forgetting to rinse the mouth. Up to 80% of an inhaled steroid dose deposits in the mouth and oropharynx. Rinsing reduces oral candidiasis from ~10–25% to under 5%.
- Loading two doses by sliding the lever twice. The lever should be slid only ONCE per dose. A second slide wastes a dose.
- Storing in the bathroom. Bathroom humidity spoils dry-powder formulations. Store the Accuhaler in a cool, dry bedroom drawer below 30 °C.
How to clean and check your Accuhaler
Wipe the mouthpiece weekly with a dry tissue — never use water inside the device. Check the dose counter regularly: when it reads 0–5, get a refill. The device locks once empty.
Seretide Accuhaler vs other ICS+LABA inhalers
| Inhaler | Steroid | LABA | Device | Best fit |
|---|---|---|---|---|
| Seretide Accuhaler | Fluticasone propionate | Salmeterol | Multi-dose DPI | Stable asthma; good inspiratory flow |
| Symbicort Turbuhaler | Budesonide | Formoterol (rapid) | DPI | SMART regimen — same inhaler for prevention + relief |
| Foracort Rotacaps | Budesonide | Formoterol | Single-cap DPI | Lower-cost alternative, capsule-loaded |
| Seretide Evohaler (MDI) | Fluticasone propionate | Salmeterol | MDI, slow inhalation needed | Patients who cannot inhale forcefully |

































Reviews
There are no reviews yet